Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 8 | |
Outperform | 14 | |
Hold | 8 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in INR
The 33 analysts offering 12 month price targets for Sun Pharmaceutical Industries Ltd have a median target of 1,820.00, with a high estimate of 2,100.00 and a low estimate of 1,291.00. The median estimate represents a -1.38% decrease from the last price of 1,845.55.
High | 13.8% | 2,100.00 |
Med | -1.4% | 1,820.00 |
Low | -30.0% | 1,291.00 |
Dividends in INR
Div growth (TTM) | 17.39% |
---|
More ▼
Earnings history & estimates in INR
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate | +4.96% |
Average growth rate | +28.63% |
More ▼
Revenue history & estimates in INR
Average growth rate | +1.51% |
Average growth rate | +10.36% |
More ▼